"HO-1 does not protect or enhance the sensitivity to neuronal death in Parkinson's disease and that pharmacological or genetic intervention on Nrf2 may provide a neuroprotective benefit as add on therapy with current symptomatic protocols"
Read abstract: Different Susceptibility to the Parkinson's Toxin ... [PLoS One. 2010] - PubMed result:
No comments:
Post a Comment